Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density
Clinical trial NCT00043186 · COMPLETED
Trial details
- NCT number
- NCT00043186
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2007-04-01
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.